Johnson & Johnson’s stock rose 2.4% in premarket trading, enough to pace the Dow Jones Industrial Average’s early gainers.

Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...

The health sector is witnessing notable developments. Bristol Myers and Pfizer are offering Eliquis at a discounted rate.

Johnson & Johnson JNJ and Pfizer PFE rank among the world’s largest pharmaceutical companies, each with broad and diversified ...

The healthcare industry offers many attractive dividend investments. Both Johnson & Johnson as well as Pfizer have a positive outlook.

Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...

The CDC has approved eligibility guidelines for the Pfizer vaccine booster. Recommendations for Moderna and Johnson & Johnson could come soon.

Comparing the COVID-19 vaccines: If you have a choice, which one should you get? Pfizer, Moderna and Johnson & Johnson are all safe and effective, but there are some differences.

Soon we will be turning another page in the pandemic playbook: A third vaccine, this one from Johnson & Johnson, looks headed to market by early March, joining vaccines from Pfizer and Moderna now ...

Health experts say not to hold out for a certain vaccine. But Pfizer, Moderna and Johnson & Johnson doses are available in Illinois. Can you choose?

According to medical experts, the Johnson & Johnson, Pfizer and Moderna COVID vaccines each offer some level of protection, but how do they compare to each ...

Johnson & Johnson's vaccine won't capture nearly as much market share as Pfizer and Moderna this year. The company's vaccine has been at a disadvantage due to a perceived lower efficacy rate. Its ...